Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic
Canada Pharmaceuticals & Healthcare Report Q1 2008
Business Monitor International, Feb 2008, Pages: 72
Description
Table of Contents
Companies Mentioned
Enquire before Buying
Send to a Friend
Executive Summary 5
Canada Pharmaceuticals And Healthcare Industry SWOT 6
Pharmaceutical Business Environment Ratings 7
Pharmaceutical Ratings - Revised Methodology 7
Ratings Overview 7
Table: Pharmaceutical Business Environment Indicators 8
Weighting 9
Table: Weighting Of Components 9
Canada - Business Enviroment Rating 10
Table: Pharmaceutical Business Environment Rankings 10
Limits To Potential Returns 10
Risks To Realisation Of Returns 11
Canada - Market Summary 12
Regulatory Regime13
Intellectual Property Developments 14
Pricing And Reimbursement Issues 16
Ontario Breaks The Mould 18
Industry Developments20
Product Approvals And Launches 21
Pharmaceutical Re-import Policy 22
Company Activity 23
National Pharmaceuticals Strategy 28
Generics Sector 29
Table: Foreign-To-Canadian Price Ratios, 2005 31
Research And Development Sector 32
Pharmacy Sector 34
Industry Forecast Scenario 36
Overall Market Forecast 36
Table: Canada: Drug Market Indicators 37
Key Growth Factors - Industry 38
Table: Canadian Health Expenditure Indicators 39
Key Growth Factors - Macroeconomic 40
Table: Canada - Macroeconomic Forecasts 41
Prescription Market Forecast 43
Table: Canadian Prescription Drug Market Forecast Indicators (US$mn unless otherwise stated) 44
OTC Market Forecast 45
Table: Canadian OTC Drugs Market Forecast Indicators (US$mn unless otherwise stated) 46
Generics Market Forecast 47
Table: Canadian Generics And Branded Market Indicators 48
Patented Market Forecast 49
Export/Import Forecasts 51
Table: Sectoral Trade Indicators (US$mn) 52
Other Healthcare Data Forecasts 53
Table: Canadian Socio-demographic Indicators 53
Competitive Landscape54
Overview 54
Table: Canada’s Leading Generics Firms, 2006 54
Company Profiles55
Leading Multinational Manufacturers 55
Pfizer 55
Merck & Co 57
GlaxoSmithKline 59
Sanofi-Aventis 61
Novartis 63
Indigenous Manufacturers 64
Apotex 64
BMI Forecast Modelling67
How We Generate Our Industry Forecasts 67
Pharmaceutical Industry 68
Sources 68
Customers who bought this item also bought
Canada Pharmaceuticals and Healthcare Report Q4 2009
Canada Pharmaceuticals and Healthcare Report Q2 2008
Canada Pharmaceuticals and Healthcare Report Q3 2007
Canada Pharmaceuticals and Healthcare Report Q3 2008
Generic Drug Market in Canada
Canada Pharmaceuticals and Healthcare Report Q4 2008
Canada Pharmaceuticals and Healthcare Report Q1 2009
Canada Pharmaceuticals and Healthcare Report Q2 2009
Canada Pharmaceutical Industry
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
The Pharmaceutical Market: Canada
Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market
Top of page
All rights reserved. © Copyright 2009 Research and Markets
1
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
